Intelligent Bio Solutions (INBS) Receivables - Net (2021 - 2024)
Intelligent Bio Solutions has reported Receivables - Net over the past 4 years, most recently at $431646.0 for Q1 2024.
- Quarterly results put Receivables - Net at $431646.0 for Q1 2024, up 45.8% from a year ago — trailing twelve months through Mar 2024 was $431646.0 (up 45.8% YoY), and the annual figure for FY2023 was $293861.0, down 86.01%.
- Receivables - Net for Q1 2024 was $431646.0 at Intelligent Bio Solutions, up from $262834.0 in the prior quarter.
- Over the last five years, Receivables - Net for INBS hit a ceiling of $2.8 million in Q4 2021 and a floor of $262834.0 in Q4 2023.
- Median Receivables - Net over the past 4 years was $431646.0 (2024), compared with a mean of $1.1 million.
- Biggest five-year swings in Receivables - Net: plummeted 90.06% in 2022 and later surged 45.8% in 2024.
- Intelligent Bio Solutions' Receivables - Net stood at $2.8 million in 2021, then plummeted by 90.06% to $278317.0 in 2022, then decreased by 5.56% to $262834.0 in 2023, then skyrocketed by 64.23% to $431646.0 in 2024.
- The last three reported values for Receivables - Net were $431646.0 (Q1 2024), $262834.0 (Q4 2023), and $567510.0 (Q3 2023) per Business Quant data.